Intangible Assets, Net (Tables)

6 Months Ended

Jun. 30, 2011

Intangible Assets, Net

Schedule Of Intangible Assets, Net

	June 30,		December 31,
	2011		2010
QOL Medical, LLC Asset Purchase Agreement, net of accumulated amortization of $10,260 and $7,980	$	44,461	$	46,741
BioAlliance Licensing Agreement, net of accumulated amortization of $1,399 and $559		-		19,441
Glenmark Generics Limited and Glenmark Generics, Inc. USA Licensing Agreement, net of accumulated amortization of $0		15,000		15,000
MonoSol Rx Licensing Agreement, net of accumulated amortization of $350 and $125		-		5,875
Trademark licensed from Bristol-Myers Squibb Company, net of accumulated amortization of $8,183 and $7,433		1,817		2,567
Genpharm, Inc. Distribution Agreement, net of accumulated amortization of $9,387 and $9,026		1,446		1,807
SVC Pharma LP License and Distribution Agreement, net of accumulated amortization of $2,723 and $2,525		961		1,159
MDRNA, Inc. Asset Purchase Agreement, net of accumulated amortization of $1,294 and $770		806		1,330
Spectrum Development and Marketing Agreement, net of accumulated amortization of $24,805 and $24,254		195		746
Other intangible assets, net of accumulated amortization of $6,336 and $5,947		887		801
	$	65,573	$	95,467

Schedule Of Estimated Amortization Expense

	Estimated
	Amortization
	Expense
2011 (remainder)	$	4,544
2012		7,122
2013		5,447
2014		4,680
2015		4,605
2016 and thereafter		39,175
	$	65,573